SYNLAB AG
Share · DE000A2TSL71 (XFRA)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | -0,18 % | -42,52 % |
Company Profile for SYNLAB AG Share
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
Company Data
Name SYNLAB AG
Company SYNLAB AG
Website
https://www.synlab.com
Primary Exchange
Frankfurt

ISIN DE000A2TSL71
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mr. Mathieu Floreani
Market Capitalization 2 Mrd.
Country Germany
Currency EUR
Employees 27,0 T
Address Moosacher Straße 88, 80809 Munich
IPO Date 2021-04-30
Dividends from 'SYNLAB AG'
Ex-Date | Dividend per Share |
---|---|
20.05.2024 | 0,33 EUR |
18.05.2023 | 0,33 EUR |
17.05.2022 | 0,33 EUR |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | SYAB.F |
XETRA | SYAB.DE |
More Shares
Investors who SYNLAB AG hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.